Vaccination is widely considered one of the greatest achievements of modern medicine. Vaccines save millions of lives and protect millions more from getting sick. However, each year roughly three million individuals still die of vaccine-preventable diseases, including respiratory infections, tuberculosis,…
The project results and materials are now available also on ResearchGate. The project page features the Fellows’ collaborative work, training and career development outputs and results of their individual projects. Follow us!
A recently published Open Access article represents the first demonstration that the plasma levels of miR-107 might represent a useful personalized diagnostic biomarker of prostate cancer since its levels are increased in plasma from prostate cancer patients compared with control…
Alexander Batista-Duharte has been invited as a guest editor of a special issue of Vaccines (ISSN 2076-393X), an Open Access journal of MDPI. The deadline for manuscript submissions is 31 March 2023. Dear Colleagues, Vaccine development has evolved from…
The sixth IMIBIC-P2Med Fellow, Silvia León Téllez, has returned to her “home group” at IMIBIC after having spent four years at the Harvard Medical School/Brigham and Women’s Hospital – The Navarro Lab (Boston-Massachusetts, USA). She returned to Cordoba in 2019…
MultiQC is an open-source tool developed by Phil Ewels, Lead for Bioinformatics developer at National Genomics Infrastructure, part of the Science for Life Laboratory in Stockholm. It aggregates results from bioinformatics analyses across many samples into a single report. Sounds…
Marina Mora and Almudena Pino both apply bioinformatics and other computational methods in their research. In 2021 they teamed up with the IMIBIC Bioinformatics Unit to organise a beginners’ course in R for basic biostatistics. Skills in this area were…
The first IMIBIC-P2Med fellow joined IMIBIC in January 2021, and four more came on board throughout the year. While the first months were taken to adapt to the new workplace and prepare everything to get their research projects ongoing, the…
The IMIBIC-P2Med fellows were part of the Organising Committee of the first edition of the IMIBIC Meeting for International Postdocs, a hybrid meeting that was held at IMIBIC on the 20th December 2021. The objective of this new event was…
In October, we welcomed the fifth IMIBIC-P2Med Fellow to IMIBIC. Alexander Batista Duharte started his fellowship with the group GC01 Immunology and Allergy, led by Prof Rafael Solana who also acts as his supervisor. As a medical doctor, a specialist…
The fourth IMIBIC-P2Med Fellow joined IMIBIC in March. It was the turn of André Morais Sarmento Borges Cabral to start his 3-year journey as a MSCA Fellow and member of the GC27 OncObesity and Metabolism research group. André will be…
Join our Fellows Maribel Martínez, Almudena Pino, André M. Sarmento B. Cabral, and Marina Mora at the ENABLE satellite session “Targeting translational biomedicine through interdisciplinary science” on 10th of May 2021. Four IMIBIC-P2Med Fellows will summarise their personal experiences as…
Seven researchers from Spain, Portugal, Cuba and India have been selected to join IMIBIC to carry out their research projects in personalised and precision medicine after a long evaluation and selection process. The first three of the selected Fellows,…
IMIBIC launched a call in October 2019 offering fellowships for recognised researchers (R2) of any nationality to carry out a project in any of the research areas of the institute and focusing on personalised and precision medicine. The selected fellows…
